Skip to main content
. 2015 Feb 9;2(1):e000018. doi: 10.1136/bmjgast-2014-000018

Figure 2.

Figure 2

Within-group comparison of stool parameters from 0 to 8 weeks (Gp, group; VAS, visual analogue scale). VSL#3 significantly decreased stool frequency, stool weight, stool mucus, diarrhoeal rate, with improvement in well-being. Mesalamine significantly decreased stool mucus and improved stool consistency and well-being.